We presented the new molecular International Prognostic Scoring System of MDS  Presenter: Prof. Spyridonidis Participants: Dr.Liga, Dr. Tsokanas, Dr. Valera Dr. Verigou Dr. Lyssandrou

Keypoints t-AML, sAML, AML-MRC can be nowadays clinically, morphologically and genetically (cytogenetics, somatic mut) identified In these pts (most > 60 y of age) CPX-351 enables efficient and safe delivery of intensive chemotherapy Consolidation with HCT in these pts is curative with real...

4o Eκπαιδευτικό Σεμινάριο στη Μεταμόσχευση Μυελού των Οστών: Πως ενσωματώνονται οι θεραπείες στόχευσης, η ανοσοθεραπεία και οι κυτταρικές θεραπείες στον σύγχρονο θεραπευτικό αλγόριθμο. Επισυνάπτεται η ομιλία της Λίγκα Μαρία Ιατρού Αιματολόγου της ΜΜΜΟ ΠΓΝΠ με τίτλο "Επιλογή δότη στην απλοταυτόσημη μεταμόσχευση" Παρουσιαστής:...

4o Eκπαιδευτικό Σεμινάριο στη Μεταμόσχευση Μυελού των Οστών: Πως ενσωματώνονται οι θεραπείες στόχευσης, η ανοσοθεραπεία και οι κυτταρικές θεραπείες στον σύγχρονο θεραπευτικό αλγόριθμο. Επισυνάπτεται η ομιλία του Τσοκάνα Δημητρίου, Ιατρού Αιματολόγου της ΜΜΜΟ ΠΓΝΠ με τίτλο "Επαναπροσδιορίζοντας τις θεραπείες επιλογής, βελτιώνοντας...

We discussed the new findings of AML MRC, secondary AML and the therapeutic option with Vyxeos Presenter Spyridonidis Particpants: Tsokanas, Liga, Valera

Presentation of a consensus document from the European LeukemiaNet MRD Working Party | Blood | American Society of Hematology Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Tsokanas Duration: 40 mins

Presenter: Gakis Georgios, 4th year undergraduate MD student Participants: Prof. Spyridonidis, Dr Liga, Dr Tsokanas Duration: 30 mins

Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Tsokanas, A. Christopoulou, E. Sagiadinou, V. Zacharioudaki, E.Triantafyllou Duration: 40 mins Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Tsokanas Duration: 30mins We discussed a case of PCNSL in an HIV patient and reviewed the literaure about the pathogenic role of EBV. In such immunocomprisised patients, the detection of EBV transcript in all of the...

Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Tsokanas Duration: 20 mins

Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Tsokanas, E. Sagiadinou, A. Christopoulou Duration: 15 mins Various reorts suggest the preferiantial use of Ankinra ver tocilizumab in  CAR T-cell associated toxicities

Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Tsokanas Duration: 25 mins Hyperbilirubinemia occurs frequently after allogeneic stem cell transplantation. Causes include primary liver damage and endothelial complications as major contributors. Here, we have investigated the impact of early bilirubinemia (EB) on posttransplant outcomes. Maximum total...

Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Tsokanas, E. Sagiadinou, A. Christopoulou Duration: 20 mins The outcome of refractory/relapsed (R/R) acute leukemias is still dismal and their treatment represents an unmet clinical need. However, allogeneic transplantation (allo-HSCT) remains the only potentially curative approach...

Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Tsokanas, E. Sagiadinou, A. Christopoulou Duration: 20 mins Pre-harvest autologous blood collection from bone marrow (BM) donors is performed to meet potential post-operative transfusion needs. This study examines the impact of autologous blood transfusion on BM...

Ομιλητής: Vincent van Dam Συμμετέχοντες: Καθ. Α. Σπυριδωνίδης, Λίγκα Μαρία, Τσοκάνας Δημήτρης, Σαγιαδινού Ελευθερία, Ζαχαριουδάκη Βασιλική, Κεφάλα Διονυσία Στα πλαίσια του Μεταπτυχιακού Προγραμματος  «Cell and Gene Therapies: from bench to bedside and Good Manufacturing Practices» πραγματοποιήθηκε τηλεδιάσκεψη με τίτλο "Elements of a QA...

Presenter: Evangelia Arampatzi, CRA Participants: Prof. Spyridonidis, Dr Liga, Dr Tsokanas, Sagiadinou E., Panagi Z. Today, on 16 March 2022 training about study protocol "AGAVE-201, A Phase 2, Open-label, Randomized, Multicenter, Study to Evaluate Efficacy, Safety and Tolerability of Axatilimab at 3...

Presenter: Gakis George Participants: Prof Spyridonidis, Dr Liga, Dr Tsokanas, E. Sagiadinou, A. Christopoulou An abstact on behalf of 28th SCHMS congress, presented by Medical student George Gakis. Chimeric antigen receptor (CAR) T-cells have revolutionized the standards of care for patients with hematologic malignancies....

A study on behalf of the Acute Leukemia Working Party of the EBMT, presented by Prof. Spyridonidis Is 8- instead of 12-Gray sufficient for acute lymphoblastic ,leukemia patients transplanted in first complete remission? Total body irradiation (TBI) continues to be an important part...